Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine insulin in cystic fibrosis patients with glucose intolerance and clinical deterioration
2005-002135-27Phase 3Completed
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of insulin glargine in cystic fibrosis-related diabetes (CFRD), cystic fibrosis (CF) and dysglycemia, sponsored by Istituto Giannina Gaslini. Started Jun 2005; status: completed.
02
Drugs
insulin glargine
03
Conditions
cystic fibrosis-related diabetes (CFRD)cystic fibrosis (CF)dysglycemia
Beyond the preview
Go deeper on 2005-002135-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002135-27.